Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 5096741, 8 pages
https://doi.org/10.1155/2017/5096741
Research Article

IL-1β and IL-6 Are Highly Expressed in RF+IgE+ Systemic Lupus Erythematous Subtype

1Department of Laboratory Medicine, West China Hospital Affiliated to Sichuan University, Chengdu, China
2Department of Rheumatology, West China Hospital Affiliated to Sichuan University, Chengdu, China
3Department of Internal Medicine, Sector Nephrology & Transplantation, Erasmus MC, Rotterdam, Netherlands

Correspondence should be addressed to Lanlan Wang

Received 19 August 2016; Accepted 14 December 2016; Published 12 February 2017

Academic Editor: Nejat K. Egilmez

Copyright © 2017 Yongkang Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Beccastrini, M. M. D'Elios, G. Emmi et al., “Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets,” International Journal of Immunopathology and Pharmacology, vol. 26, no. 3, pp. 585–596, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kaul, C. Gordon, M. K. Crow et al., “Systemic lupus erythematosus,” Nature Reviews Disease Primers, vol. 2, Article ID 16039, 2016. View at Publisher · View at Google Scholar
  3. T. N. Marion and A. E. Postlethwaite, “Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus,” Seminars in Immunopathology, vol. 36, no. 5, pp. 495–517, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Perkins, R. W. Hoffman, and N. Bezruczko, “A Rasch analysis for classification of systemic lupus erythematosus and mixed connective tissue disease,” Journal of Applied Measurement, vol. 9, no. 2, pp. 136–150, 2008. View at Google Scholar · View at Scopus
  5. J. De Azevêdo Silva, C. Addobbati, P. Sandrin-Garcia, and S. Crovella, “Systemic lupus erythematosus: old and new susceptibility genes versus clinical manifestations,” Current Genomics, vol. 15, no. 1, pp. 52–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Ni, J. Liu, R.-X. Leng, H.-F. Pan, and D.-Q. Ye, “Genetic polymorphism (rs329498) in the Pellino-1 gene as possible predisposal factor for systemic lupus erythematosus in a Chinese population,” Immunological Investigations, vol. 45, no. 3, pp. 181–190, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Liu, J. Liu, J. Ni, R. X. Leng, H. F. Pan, and D. Q. Ye, “Association of UBASH3A gene polymorphisms and systemic lupus erythematosus in a Chinese population,” Gene, vol. 565, no. 1, pp. 116–121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. P. López, J. Rodríguez-Carrio, and A. Suárez, “Antimalarial drugs inhibit IFNα-enhanced TNFα and STAT4 expression in monocytes: implication for systemic lupus erythematosus,” Cytokine, vol. 67, no. 1, pp. 13–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. B. Lozovoy, A. N. C. Simão, H. K. Morimoto et al., “Hypertension is associated with serologically active disease in patients with systemic lupus erythematosus: role of increased Th1/Th2 ratio and oxidative stress,” Scandinavian Journal of Rheumatology, vol. 43, no. 1, pp. 59–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Quandt, K. Rothe, R. Scholz, C. W. Baerwald, and U. Wagner, “Peripheral CD4CD8 double positive t cells with a distinct helper cytokine profile are increased in rheumatoid arthritis,” PLOS ONE, vol. 9, no. 3, Article ID e93293, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Zamora-Atenza, C. Diaz-Torne, C. Geli et al., “Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis,” Arthritis Research and Therapy, vol. 16, no. 4, article no. R153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. B. J. M. Ripley, B. Goncalves, D. A. Isenberg, D. S. Latchman, and A. Rahman, “Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia,” Annals of the Rheumatic Diseases, vol. 64, no. 6, pp. 849–853, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. G. Song, S. J. Choi, J. D. Ji, and Y. H. Lee, “Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis,” Molecular Biology Reports, vol. 40, no. 3, pp. 2581–2587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. H. Lee, H. S. Lee, S. J. Choi, J. D. Ji, and G. G. Song, “The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis,” Lupus, vol. 21, no. 1, pp. 60–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Wais, W. Fierz, T. Stoll, and P. M. Villiger, “Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission,” Journal of Rheumatology, vol. 30, no. 10, pp. 2133–2139, 2003. View at Google Scholar · View at Scopus
  16. Y. Wu, Z. Huang, Y. Shi et al., “Systemic Lupus Erythematosus (SLE) risk factors: novel proteins detected from familial SLE using proteomics,” Laboratory Medicine, vol. 40, no. 7, pp. 408–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Sokolove, D. S. Johnson, L. J. Lahey et al., “Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis,” Arthritis and Rheumatology, vol. 66, no. 4, pp. 813–821, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. H. J. Gould, B. J. Sutton, A. J. Beavil et al., “The biology of IgE and the basis of allergic disease,” Annual Review of Immunology, vol. 21, pp. 579–628, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. P. S. Ramos, J. A. Kelly, C. Gray-McGuire et al., “Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus,” Genes and Immunity, vol. 7, no. 5, pp. 417–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Sanjuan, D. Sagar, and R. Kolbeck, “Role of IgE in autoimmunity,” Journal of Allergy and Clinical Immunology, vol. 137, no. 6, pp. 1651–1661, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Xue, L. Gao, Y. Wu et al., “The IL-16 gene polymorphisms and the risk of the systemic lupus erythematosus,” Clinica Chimica Acta, vol. 403, no. 1-2, pp. 223–225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Ferri, A. Gigante, F. Ferri et al., “Urine chemokines: biomarkers of human lupus nephritis?” European Review for Medical and Pharmacological Sciences, vol. 11, no. 3, pp. 171–178, 2007. View at Google Scholar · View at Scopus
  23. L. M. Amezcua-Guerra, V. Higuera-Ortiz, U. Arteaga-García, S. Gallegos-Nava, and C. Hübbe-Tena, “Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology classification criteria for systemic lupus erythematosus in a real-life scenario,” Arthritis Care and Research, vol. 67, no. 3, pp. 437–441, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Alarcón-Segovia, M. E. Alarcón-Riquelme, M. H. Cardiel et al., “Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1138–1147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Deapen, A. Escalante, L. Weinrib et al., “A revised estimate of twin concordance in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 35, no. 3, pp. 311–318, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. Moser, J. A. Kelly, C. J. Lessard, and J. B. Harley, “Recent insights into the genetic basis of systemic lupus erythematosus,” Genes and Immunity, vol. 10, no. 5, pp. 373–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Kaneko, M. Kuwana, H. Kameda, and T. Takeuchi, “Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria,” Rheumatology, vol. 50, no. 7, pp. 1268–1274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Popescu, S. Zofota, V. Bojinca, and R. Ionescu, “The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus,” Romanian Journal of Internal Medicine, vol. 51, no. 3-4, pp. 179–187, 2013. View at Google Scholar · View at Scopus
  29. T. L. Skare, M. B. Silva, A. P. Holler, and P. A. Chavez, “Protective role of rheumatoid factor in lupus nephritis,” Clinical and Experimental Rheumatology, vol. 27, no. 5, article 895, 2009. View at Google Scholar · View at Scopus
  30. X.-J. Zhou, S. K. Nath, Y.-Y. Qi et al., “Brief report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern han chinese by shared-gene analysis with IgA nephropathy,” Arthritis and Rheumatology, vol. 66, no. 10, pp. 2842–2848, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. Atta, C. P. Sousa, E. M. Carvalho, and M. L. B. Sousa-Atta, “Immunoglobulin E and systemic lupus erythematosus,” Brazilian Journal of Medical and Biological Research, vol. 37, no. 10, pp. 1497–1501, 2004. View at Google Scholar · View at Scopus
  32. B. Dema, C. Pellefigues, S. Hasni et al., “Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis,” PLoS ONE, vol. 9, no. 2, Article ID e90424, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Atta, M. B. Santiago, F. G. Guerra, M. M. Pereira, and M. L. B. S. Atta, “Autoimmune response of IgE antibodies to cellular self-antigens in systemic lupus erythematosus,” International Archives of Allergy and Immunology, vol. 152, no. 4, pp. 401–406, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. B. L. Liphaus and M. H. B. Kiss, “The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus,” Clinics, vol. 65, no. 3, pp. 327–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. R. S. Geha, “Regulation of IgE synthesis in humans,” The Journal of Allergy and Clinical Immunology, vol. 90, no. 2, pp. 143–150, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Sin, P. Anand, and M. Frieri, “A link: allergic rhinitis, Asthma & Systemic Lupus Erythematosus,” Autoimmunity Reviews, vol. 15, no. 5, pp. 487–491, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Sasai, S. Furukawa, H. Hashimoto, and K. Yabuta, “Increased levels of serum IgE in children of mothers with systemic lupus erythematosus,” Allergy, vol. 50, no. 4, pp. 370–373, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-Q. Ni, Q. Ouyang, L. Lin et al., “Role of toll-like receptor 4 on lupus lung injury and atherosclerosis in LPS-challenge ApoE−/− mice,” Clinical and Developmental Immunology, vol. 2013, Article ID 476856, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Feng, J. Wu, X. Feng et al., “Timing of apoptosis onset depends on cell cycle progression in peripheral blood lymphocytes and lymphocytic leukemia cells,” Oncology Reports, vol. 17, no. 6, pp. 1437–1444, 2007. View at Google Scholar · View at Scopus
  40. H. Trébéden-Nègre, B. Weill, C. Fournier, and F. Batteux, “B cell apoptosis accelerates the onset of murine lupus,” European Journal of Immunology, vol. 33, no. 6, pp. 1603–1612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. D. P. Harris, L. Haynes, P. C. Sayles et al., “Reciprocal regulation of polarized cytokine production by effector B and T cells,” Nature Immunology, vol. 1, no. 6, pp. 475–482, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Avramescu, V. Biciusca, T. Daianu et al., “Cytokine panel and histopathological aspects in the systemic lupus erythematosus,” Romanian Journal of Morphology and Embryology, vol. 51, no. 4, pp. 633–640, 2010. View at Google Scholar
  43. L. S. Davis, J. Hutcheson, and C. Mohan, “The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus,” Journal of Interferon and Cytokine Research, vol. 31, no. 10, pp. 781–789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Umare, V. Pradhan, M. Nadkar et al., “Effect of proinflammatory cytokines (IL-6, TNF, and IL-1 β) on clinical manifestations in indian SLE patients,” Mediators of Inflammation, vol. 2014, Article ID 385297, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Berntson, E. Nordal, A. Fasth et al., “Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA),” Pediatric Rheumatology Online Journal, vol. 12, article 22, 2014. View at Google Scholar
  46. J.-B. Wang, H. Li, L.-L. Wang, H.-D. Liang, L. Zhao, and J. Dong, “Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 9, pp. 16658–16663, 2015. View at Google Scholar · View at Scopus
  47. S. A. Apostolidis, L. A. Lieberman, K. Kis-Toth, J. C. Crispín, and G. C. Tsokos, “The dysregulation of cytokine networks in systemic lupus erythematosus,” Journal of Interferon and Cytokine Research, vol. 31, no. 10, pp. 769–779, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. C. M. Fremond, D. Togbe, E. Doz et al., “IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection,” The Journal of Immunology, vol. 179, no. 2, pp. 1178–1189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. A. X. H. Goh, S. Bertin-Maghit, S. P. Yeo et al., “A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy,” mAbs, vol. 6, no. 3, pp. 765–773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. G. J. Prud'Homme, B. R. Lawson, and A. N. Theofilopoulos, “Anticytokine gene therapy of autoimmune diseases,” Expert Opinion on Biological Therapy, vol. 1, no. 3, pp. 359–373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Gijbels, S. Brocke, J. S. Abrams, and L. Steinman, “Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation,” Molecular Medicine, vol. 1, no. 7, pp. 795–805, 1995. View at Google Scholar · View at Scopus
  52. U. Thanarajasingam and T. B. Niewold, “Sirukumab: a novel therapy for lupus nephritis?” Expert Opinion on Investigational Drugs, vol. 23, no. 10, pp. 1449–1455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Ocampo, D. Haaland, K. Legault, S. Mittoo, and E. Aitken, “Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous,” BMJ Case Reports, vol. 2016, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Iwai, T. Naniwa, S. Tamechika, and S. Maeda, “Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis,” Modern Rheumatology, pp. 1–4, 2014. View at Publisher · View at Google Scholar